Mammography systems are specialized breast imaging platforms used for the early detection, diagnosis, and monitoring of breast cancer. These systems include analog and digital mammography technologies, with modern platforms increasingly incorporating digital breast tomosynthesis (DBT), AI-assisted image analysis, dose optimization, and advanced workflow automation capabilities.
As breast cancer remains the most commonly diagnosed cancer among women globally, mammography continues to serve as the primary screening tool across hospitals, breast care centers, diagnostic imaging facilities, and national screening programs. The evolution from conventional imaging to advanced digital systems has improved image quality, lesion detection, diagnostic confidence, patient comfort, and clinical efficiency.
According to BIS Research, the Global Mammography Systems Market was valued at $2,663.0 million in 2025 and is projected to reach $6,375.3 million by 2036, growing at a CAGR of 8.29% during the forecast period from 2026 to 2036.
Download the complete TOC and Request Sample Report
• Rising incidence of breast cancer worldwide and increasing demand for early detection
• Expansion of national and regional breast cancer screening programs
• Growing adoption of digital mammography and digital breast tomosynthesis (DBT) systems
• Integration of AI-assisted image interpretation and intelligent workflow solutions
• Increasing investments in women's healthcare infrastructure and diagnostic imaging technologies
• Improved image quality, dose management, and patient positioning technologies enhancing diagnostic outcomes
• Global shortage of trained radiologists and mammography technologists
• High capital investment and infrastructure requirements for advanced imaging systems
• Reimbursement variability across different healthcare markets
• Uneven access to breast imaging services in rural and underserved regions
• Limited availability of specialized breast imaging expertise in emerging economies
• November 2025: GE HealthCare received FDA Premarket Authorization for Pristina Recon DL, a deep learning-based 3D mammography image reconstruction technology designed to enhance image clarity and sharpness.
• November 2025: Siemens Healthineers introduced enhanced capabilities for its Mammomat B.brilliant mammography platform, improving contrast-enhanced imaging and biopsy functionality.
• May 2025: Siemens Healthineers launched the MAMMOMAT B.brilliant mammography system in Indonesia to strengthen breast imaging capabilities in the region.
• November 2024: GE HealthCare introduced the Pristina Via mammography system, designed to improve both patient and technologist experience during breast screening procedures.
• Analog Mammography Systems
• Digital Mammography Systems
• Hospitals and Ambulatory Surgical Centers
• Diagnostics Center
• Other End User
• North America
o U.S.
o Canada
• Europe
o U.K.
o Germany
o France
o Italy
o Spain
o Rest-of-Europe
• Asia-Pacific
o China
o Japan
o India
o Australia
o South Korea
o Rest-of-Asia-Pacific
• Latin America
o Brazil
o Mexico
o Rest-of-Latin America
• Middle East and Africa
According to Principal Consultant at BIS Research: "The mammography systems market is a mature yet steadily expanding segment supported by the increasing global burden of breast cancer and the continued emphasis on early diagnosis. Developed regions such as North America and Europe continue to lead adoption due to established screening frameworks, reimbursement support, and ongoing technology upgrades, particularly in digital breast tomosynthesis. Meanwhile, emerging economies are creating significant growth opportunities through expanding screening initiatives and investments in diagnostic infrastructure. Advances in AI-enabled imaging, workflow automation, and enhanced breast visualization technologies are expected to further strengthen the role of mammography systems as a cornerstone of modern breast cancer care."
The global mammography systems market is expected to grow from $2,663.0 million in 2025 to $6,375.3 million by 2036, registering a CAGR of 8.29% during the forecast period.
Major companies operating in the mammography systems market include Hologic, Inc., GE HealthCare, Siemens Healthineers, FUJIFILM, Canon Medical Systems, Planmed Oy, and Metaltronica.
Digital mammography systems currently dominate the market due to their clinical effectiveness, affordability, workflow integration, and widespread adoption. Digital breast tomosynthesis (DBT), AI-assisted image interpretation, and advanced 3D imaging technologies are also witnessing increasing demand.
BIS Research provides expert-driven market intelligence, technology assessments, competitive benchmarking, and strategic advisory services across healthcare, medical devices, diagnostics, and emerging healthcare technologies.
